When: Wednesday September 18th at 6 pm.
Where: Zoom, you can register here.
Presenter Tian Wang, a molecular biologist who is currently Program Manager for the Hearing Restoration Project (a medical research program directly funded by Congress) will share with us why SNHL is so hard to treat. With no agreed to underlying disease biology, SNHL treatments in trial are somewhat a shot in the dark with very low success rates. Currently no approved FDA drugs exist although recent gene mutation reversal efforts show promise. Tian will talk about exciting projects planned and what we as consumers can do to support hearing research.
